한미약품은 창조와 도전을 기치로 신약개발에 매진하는 R&D중심 제약기업입니다.
Cephalosporin antibiotics is world's most well accepted, broad spectrum antibiotic.
Hanmi Cepha Plant is a Cephalosporin antibiotics dedicated manufacturing facility, producing both oral and injectable dosage forms. It has state-of-the art production facilities with the largest production capacity for Cephalosporin products in Korea. High quality standards in compliance with current international GMP regulations are maintained throughout the manufacturing process and product quality control.
Hanmi Cepha plant was established in 2007 and accredited with KGMP in the same year. It was awarded for self-audit from MFDS in 2010. In 2013, it was granted EU GMP certification from the German authority (LSJV), and Ceftriaxone Inj. was exported to EU for the first time in Korea.
|Floor||Area size (m2)||Floor Activities|
|3rd||2,820||Oral solid area, QC laboratories|
|2nd||995||QA office, control room, GMP library, gowning area for packaging|
|1st||3,030||Parenteral area, general office, material receiving and shippping|
|B1||2,913||HVAC, water treatment system, engineering room|